PLIANT THERAPEUTICS, INC. Debt Securities, Available-for-sale, Amortized Cost
PLIANT THERAPEUTICS, INC. (PLRX) had Debt Securities, Available-for-sale, Amortized Cost of $422.02 million as of 2024-06-30, per its 10-Q filed 2024-08-07.
Discontinued › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2024-08-07
- 2024-06-30: Debt Securities, Available-for-sale, Amortized Cost $422.02M.
- 2024-03-31: Debt Securities, Available-for-sale, Amortized Cost $451.91M.
- 2023-12-31: Debt Securities, Available-for-sale, Amortized Cost $487.91M.
- 2023-09-30: Debt Securities, Available-for-sale, Amortized Cost $520.09M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2024-06-30 | $422.02M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $451.91M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $487.91M 10-Q · filed 2024-08-07 |
| 2023-09-30 | $520.09M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $550.26M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $559.16M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $327.77M 10-K · filed 2024-02-27 |
| 2022-09-30 | $345.51M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $154.36M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $164.00M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $183.96M 10-K · filed 2023-03-09 |
| 2021-09-30 | $203.83M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $233.81M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $243.85M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $263.73M 10-K · filed 2022-03-01 |
| 2020-09-30 | $273.73M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $273.95M 10-Q · filed 2020-08-11 |
| 2019-12-31 | $53.57M 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |